 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Stoke Therapeutics Inc. (STOK)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-02 Sale | 2020-03-04 7:25 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 49,143 | $25.89 | $1,272,549 | 0 (Direct) | View |
| 2019-11-08 Sale | 2019-11-12 4:42 pm | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 16,434 | $28.7 | $471,631 | 3,544,248 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-06 6:52 pm | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 104,873 | $29.24 | $3,066,843 | 3,560,682 (Indirect) | View |
| 2019-10-30 Purchase | 2019-11-01 4:55 pm | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 68,783 | $28.59 | $1,966,613 | 3,455,809 (Indirect) | View |
| 2019-10-01 Purchase | 2019-10-02 1:20 pm | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 31,560 | $21.96 | $693,029 | 3,387,026 (Indirect) | View |
| 2019-06-21 Purchase | 2019-06-21 5:01 pm | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 1,388,889 | $18 | $25,000,002 | 16,786,712 (Indirect) | View |
| 2019-06-21 Purchase | 2019-06-21 4:59 pm | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 1,388,889 | $18 | $25,000,002 | 16,786,712 (Direct) | View |
| 2019-06-19 Purchase | 2019-06-20 09:50 am | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 555,556 | $18 | $10,000,008 | 3,355,466 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-25 Option Award | 2020-03-26 6:08 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Walker Robin A. Chief Legal Officer CCO & Sec | 60,000 | $20.25 | 60,000 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:07 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 60,000 | $20.25 | 60,000 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:05 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 60,000 | $20.25 | 60,000 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:04 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Liau Gene VP | 42,000 | $20.25 | 42,000 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:02 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 197,000 | $20.25 | 197,000 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:01 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 60,000 | $20.25 | 60,000 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 7:25 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 6,324 | $0.4 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 7:25 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 42,779 | $2.19 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 7:25 pm | N/A 2026-02-11 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 6,324 | $0.4 | 0 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 7:25 pm | N/A 2018-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 42,779 | $2.19 | 0 (Direct) | View |
| 2019-11-15 Option Award | 2019-11-18 5:00 pm | N/A 2029-11-14 | Stoke Therapeutics Inc. | STOK | Walker Robin A. Chief Legal Officer | 84,800 | $23.32 | 84,800 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:11 pm | N/A 2019-09-09 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 29,555 | $28.8 | 29,555 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:10 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | Hall Samuel W. Director 10% Owner | 29,555 | $28.8 | 29,555 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:08 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director | 29,555 | $28.8 | 29,555 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:07 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 14,777 | $28.8 | 14,777 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:06 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 14,777 | $28.8 | 14,777 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 8:04 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 14,777 | $28.8 | 14,777 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-24 6:23 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Redmile Group LLC Green Jeremy 10% Owner | 671,808 | $0 | 0 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-24 6:23 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Redmile Group LLC Green Jeremy 10% Owner | 671,808 | $0 | 0 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 4,980,168 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 7,617,746 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 2,799,910 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 4,980,168 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 7,617,746 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 5:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 2,799,910 | $0 | 16,786,712 (Indirect) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 4,980,168 | $0 | 16,786,712 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 7,617,746 | $0 | 16,786,712 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 2,799,910 | $0 | 16,786,712 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 4,980,168 | $0 | 16,786,712 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 7,617,746 | $0 | 16,786,712 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 2,799,910 | $0 | 16,786,712 (Direct) | View |
| 2019-06-19 Conversion | 2019-06-20 09:50 am | N/A N/A | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2,799,910 | $0 | 3,355,466 (Indirect) | View |
| 2019-06-19 Conversion | 2019-06-20 09:50 am | N/A N/A | Stoke Therapeutics Inc. | STOK | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2,799,910 | $0 | 3,355,466 (Indirect) | View |